Alerta De Seguridad para Trade name: LIPASE RANDOX. Technical Name: LIPASE. ANVISA registration number: 80158990110. Risk class: II. Affected Model: LI3837, LI7979

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por RANDOX BRASIL LTDA; RANDOX LABORATORIES LTD.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    1931
  • Fecha
    2016-06-13
  • País del evento
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    Follow manufacturer's guidelines (Attached) If you wish to notify technical complaints and adverse events use the following channels: Notivisa: Notices of adverse events (AEs) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System . To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link
  • Causa
    There is a possibility of transitioning from the triglyceride reagent probe and direct ldl to lipase to rx equipment, which may cause elevated lipase results. this can occur if lipase is directly positioned before or after triglycerides or direct ldl in the order of assays in these equipment.
  • Acción
    Update the reagent installation with the correct settings using the data provided by the manufacturer (Letter to the attached clients). Field action classification: Aldolase specific application protocol for Rola Imola equipment Field action code: 7f06.0001

Manufacturer